/DaVita%20Inc%20logo%20on%20building-by%20JHVEPhoto%20via%20iStock.jpg)
Valued at $12.8 billion by market cap, DaVita Inc. (DVA) is a prominent healthcare company specializing in kidney care and dialysis services for patients with chronic kidney disease and end-stage renal disease. Headquartered in Denver, the company operates one of the world’s largest dialysis networks, providing treatment through thousands of outpatient centers as well as home dialysis programs across the U.S. and international markets.
Shares of this kidney care giant have exceeded the broader market over the past year. DVA has soared 38.9% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 26.6%. In 2026, DVA stock is up 76.5%, compared to the SPX’s 8.1% rise on a YTD basis.
